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Some basic premises must be considered when validating
hypothesis about progression of renal disease. In an
accompanying series of five articles, specific aspects of
progression will be reviewed by experts in the field:
mechanisms of tissue and matrix remodelling; interstitial
fibrosis; the contribution of ischemia and hypoxia; the role
and type of the inflammatory infiltrate; and, finally,
glomerular sclerosis.
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BASIC CONSIDERATIONS CONCERNING PROGRESSION OF
RENAL DISEASE
Chronic progressive renal disease is characterized by
glomerulosclerosis, interstitial leukocyte infiltration, tubular
atrophy, and tubulointerstitial fibrosis.1 Involvement of both
the tubulointerstitium and the glomeruli contributes to
progression and, hence, prognosis of all renal diseases.
Glomerular sclerosis may be associated with podocyte loss
with or without inflammatory and proliferative components.
In contrast, in the tubulointerstitial compartment, progres-
sive fibrosis is always associated with persistent sterile
inflammation. The latter is initiated by the generation of
soluble mediators in response to local cell stress and tissue
injury, resulting in the infiltration of leukocytes, and
subsequent secretion of various mediators by infiltrating
and resident bone marrow (BM)-derived cells, as well as
by tubular epithelial cells and interstitial fibroblasts
(see Figure 1). Together, these actions attempt to correct
and repair local tissue damage, but also result in the
activation of profibrotic cells, predominantly myofibroblasts,
and a local scar formation or fibrosis.1 Fibrosis, in turn,
entails distortion of the intricate cellular architecture of the
nephron, initiating a vicious cycle and posing further
challenges to cellular homeostasis. As these considerations
apply to the process of fibrosis in any organ, hypotheses
about progressive fibrosis in renal disease should include
(1) the anatomical and physiological make-up of the kidney
and the nephron and
(2) the basic principles of the pathology of tissue injury and
repair.
One should keep in mind that a hypothesis and its
experimental support is limited by what we can measure. This
idea should be obvious when looking at the historical
development of renal pathology from gross anatomy and
histopathology to cellular, ultrastructural, molecular, and
genomic levels. What we can measure creates certain areas of
emphasis in research that may or may not reflect the
significance of the scientific question being asked. The
frequently quoted observation that tubulointerstitial changes
are the best predictors of renal function and prognosis may be a
case in point. Perhaps, the basis for this statement is founded
more in the pathologists’ capability to preferentially measure
and quantify changes in the tubulointerstitial space, which
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accounts for more than 90% of the cortical tissue, rather than
determining changes in functional glomerular capillary area, an
entity comprising less than 10% of the cortical area occupied by
glomeruli. Furthermore, at present functional capillary area
cannot be determined in routine renal histopathology. With the
advent of novel methodology, different parameters can be
measured, resulting in novel hypotheses. For example, the
advent of reliable markers for podocyte quantification allowed
investigators to determine the number of surviving podocytes
per glomerulus, generating a novel paradigm whereby loss of
podocytes is now considered a major determinant and
prognostic indicator for glomerular sclerosis.2
The ability to preferentially culture certain types of cells
may serve as another example of how methodology leaves its
imprint on the prominence assigned to a specific area of
research. The technical advances in cell culture generated an
initial wave of enthusiasm for research on renal tubular
epithelial cells, which was followed by the mesangial cell swell
and, presently, the podocyte megasurf. Unfortunately, at
present no reliable cell culture system exists for differentiated
glomerular and peritubular endothelial cells, so this
important cell type remains somewhat neglected in the
pathophysiology of renal disease.3 Similar considerations may
apply to the renal lymphatics, and the intrarenal network of
interstitial and dendritic cells.4,5 Should these limitations be
overcome, renal glomerular and peritubular capillary and
lymphatic endothelial cells, interstitial cells, and dendritic
cells will probably occupy center stage and shine in the
limelight of renal research, at least for a while.
Fortunately, the limitations of cell culture experiments can
be compensated by the advent of cell-specific knockout and
knock-in systems for genes or mutated genes in mice. These
systems allow the validation and extension of at least some of
the cell culture data in vivo. Furthermore, genomic and
proteomic approaches allow the experimental cell culture and
animal data to translate to human renal diseases using renal
biopsies and urine from patients. This field is still in the
developmental phase and should evolve considerably during
the next decade, including the evaluation of pathway analysis
because of the advances in system’s biology.
ANATOMICAL AND FUNCTIONAL MAKE UP OF THE KIDNEY
The glomerular and peritubular microvasculature are
arranged in sequence
Essentially, the renal microvasculature is organized into two
capillary beds in sequence, that is, the glomerular capillary
Glomerular damage
• Intracapillary hypertension
• Immunological injury
• Metabolic injury: glucose,
lipids, paraproteins
• Genetic defects
Glomerular consequences
• Diminished production of growth factors
• Altered cell–matrix interactions
• Expansion of mesangial
matrix and basement membrane
• Proliferation or loss of mesangial
and endothelial cells
• Changes in podocyte biology
• Loss of podocytes
• Altered permselectivity and proteinuria
• Reduction in glomerular
capillary area and blood flow
Tubular damage
• Toxic or metabolic: glucose, lipids,
filtered proteins, complement,
cytokines either from ultrafiltrate or
peritubular circulation
• Ischemia/hypoxia
Tubular consequences
• Endoplasmic reticulum stress
• Generation of reactive oxygen species
• Generation of mediators of inflammation
• Altered generation of cytokines and growth factors
• Change in extracellular matrix turnover
• Generation of damage-associated 
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• Tubular epithelial apaptosis
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Peritubular capillary damage
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blood flow or interstitial fibrosis
• Loss of endothelial growth factors
• Generation of proapoptotic factors
by infiltrating leukocytes
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Interstitial damage
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Interstitial consequences
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• Activation of resident monocytes/dendritic cells
• Infiltration and activation of inflammatory cells
• Infiltration of bone-marrow-derived fibrocytes
• Fibroblast activation and proliferation
to myofibroblast
• Altered matrix turnover and fibrosis
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Figure 1 | Overall scheme of factors and pathways contributing to the progression of renal disease.
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convolute and the peritubular capillary network. This
sequential organization allows for an exquisite balance
between glomerular filtration and tubular reabsorption, that
is, the maintenance of glomerulo-tubular balance. The
downside of this dynamic, adaptive, and fine-tuned system
is its vulnerability to upstream interference with blood flow; a
decrease in preglomerular or glomerular blood flow will
inevitably jeopardize the downstream peritubular blood flow.
This is especially pertinent as there is essentially no collateral
blood supply for the post-glomerular microcirculation. Thus,
any acute or chronic glomerular injury, with a decrease in
glomerular blood flow, is associated with an obligatory
reduction in peritubular blood flow. Depending on the
degree of resulting hypoxia, this entails tubulointerstitial
injury and tissue remodeling. The glomerular capillaries are
especially vulnerable, in contrast to other capillary beds,
because they are exposed to high intra- and trans-capillary
pressures even under normal physiological conditions.6,7 The
identification by Brenner and co-workers7 of glomerular
hypertension and hyperfiltration as significant contributors
to progressive renal disease has resulted in major therapeutic
advances for the prevention and treatment of progressive
renal insufficiency in hypertension, diabetes and other
glomerular diseases. This is achieved by reducing intraglo-
merular pressure, most commonly by blocking the angio-
tensin system. As to be expected, the preservation of
glomerular morphology and function by blocking angioten-
sin II also prevents downstream loss of peritubular capillaries
and interstitial fibrosis.6 These studies also illustrate that the
glomerular ultrafiltration apparatus represents a functional
unit, as all of its components, that is endothelial and
mesangial cells, basement membrane, and podocytes, are
affected by glomerular hypertension, albeit to a variable
degree. In this context, it becomes irrelevant whether the
glomerular hyperfiltration/hypertension is part of the
primary disease (for example, hypertension or diabetes) or
occurs secondary to progressive nephron loss in any form of
renal disease. The increased intracapillary pressure causes
mesangial cell hypertrophy and matrix expansion, changes in
basement membrane–podocyte interactions, podocyte hyper-
trophy, and eventually apoptosis with podocyte loss and
glomerulosclerosis. Loss of podocytes leads to reduced
vascular endothelial growth factor production and thereby
glomerular endothelial apoptosis.1,6 For reasons pointed out
above, the role of the glomerular endothelial cells in these
processes is understudied at present. Irrespective of the
initiating process, the net result is rarefication or even total
loss of glomerular capillary loops translating into diminished
postglomerular, peritubular blood flow and consequently
tubular ischemia and hypoxia (Figure 1). A contribution to
this series by Norman and Fine will discuss this process. On
the basis of the determination of renal cortical oxygen
tension by O2 electrodes,
8 the general notion is that O2
tension should be high in the glomerulus. This assumption
may not be correct for the visceral and parietal glomerular
epithelial cells, as the O2 tension in the hemoglobin free
primary ultrafiltrate bathing these cells has never been
determined under physiological or pathological conditions.
Another consequence of the peritubular circulation being
downstream of the glomerulus is that, in proliferative and
sclerosing forms of glomerulonephritis, inflammatory and
profibrotic mediators generated within the glomerulus may
spill over and activate the endothelium of the peritubular
microcirculation, thus contributing to the secondary inter-
sititial inflammatory reaction. In contrast, in noninflamma-
tory and nonsclerosing glomerular lesions such as minimal
change disease, no inflammatory mediators are generated in
the glomerulus and consequently none spill over into the
peritubular capillaries. This hypothesis is compatible with the
lack of secondary interstitial involvement in the selective,
noninflammatory proteinuria of minimal change disease.
Another consequence of the sequential arrangement of the
capillary beds is that there are two potential sites for
leukocyte extravasation during inflammatory renal disease:
the glomerulus and the peritubular capillaries and venules.
These vascular compartments are characterized by different
endothelial adhesion molecules, which may contribute to the
different inflammatory cell infiltrates occurring in the
glomerulus and interstitium.1
GLOMERULAR AND TUBULAR FUNCTIONS ARE ORGANIZED IN
SEQUENCE
The downstream position of the tubulus with respect to the
glomerulus does not only apply to the blood flow but also to
the ultrafiltrate, which may become another avenue for
spreading primarily glomerular disease to the tubulointer-
stitial compartment. The proteinuric ultrafiltrate may con-
tain mediators of inflammation generated in the glomerulus
(as above) as well as a variety of potentially noxious
substances. The filtered mediators could directly initiate an
inflammatory response at the tubular level, whereas the
noxious substances may in turn set off tubular epithelial
injury with secondary generation of inflammatory mediators,
tubular apoptosis, and peritubular inflammation.1 A con-
tribution to this series by Strutz addresses this issue. Thus, in
primary glomerular diseases, the downstream position of the
tubulointerstitium, both in terms of blood and utlrafiltration
flow, may lead to secondary involvement and injury of the
tubulointerstitial compartment (see Figure 1).
BASIC CONSIDERATIONS FOR THE PATHOLOGY OF RENAL
INJURY AND REPAIR
Tissue injury of any kind generates mediators of inflamma-
tion. Cells can adapt to stress within certain limits because of
enhanced generation of molecules protecting against reactive
oxygen species; the endoplasmic reticulum stress response;
and proteasomal degradation and autophagy.
If the adaptive capacity of the cell is exceeded, injury
becomes irreversible and cell death occurs. Cell death follows
two major patterns, necrosis and apoptosis, with some
overlap. Necrosis is characterized by cellular swelling, protein
denaturation, and breakdown of intracellular organelles with
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release of proinflammatory products, resulting in inflamma-
tion. In contrast, apoptosis is a controlled and programmed
form of cell dismantling with intracellular breakdown of
proteins, RNA and DNA, and rapid phagocytic uptake of
residual apoptotic bodies by neighboring cells or infiltrating
leukocytes. The uptake of apoptotic particles by leukocytes
initiates an anti-inflammatory program, so that apoptosis
does not result in inflammation in general.1 However,
delayed and incomplete removal of apoptotic bodies may
also initiate local generation of mediators of inflammation
and subsequent leukocyte infiltration.
In the kidney, causes of injury are based on immunologic
reactions (immune complexes or immune cells), oxygen
deprivation (local hypoxia as well as ischemia), chemical
agents (ranging from drugs to endogenous substances in high
concentrations such as glucose), and genetic defects.
Preservation of mitochondrial function may play a promi-
nent role in cell protection, whereas generation of reactive
oxygen species appears to be a common factor in injury.1,9
Endoplasmic reticulum stress, mitochondrial dysfunction,
oxidative modification of lipids, proteins, and DNA may
initiate apoptosis and necrosis, resulting in an inflammatory
process. Hypoxia/ischemia secondary to loss of capillaries
also contributes to reactive oxygen species generation and to
the release of damage associated molecular pattern (DAMP)
molecules, which may activate Toll-like receptors (TLR),
thereby further enhancing the inflammatory process and
tissue remodeling.1,10,11
IN THE POSTEMBRYONIC STATE REPAIR INVOLVES
INFLAMMATION
Only in the embryo can loss or damage of tissue be repaired
without inflammation, scarring, or fibrosis.12 After birth,
repair is always associated with an inflammatory process,
irrespective of the eventual outcome, such as healing, limited,
or progressive fibrosis. Overall, local tissue injury follows a
rather uniform scenario involving the release or generation of
soluble factors, an increase in local vascular permeability,
activation of endothelial cells, and the emigration of
leukocytes.1 This will be discussed by Hughes and co-authors
in a contribution to this series. As in other tissues, injury to
renal cells can generate soluble mediators, including
chemokines, cytokines, growth factors, (for example, vascular
endothelial, platelet-derived, hepatocyte, epidermal, fibro-
blast, insulin-like growth factors, transforming growth factor
ß, and bone morphogenetic protein) and lipid mediators (for
example,, prostanoids, leukotrienes, lipoxins, and platelet-
activating factor). Stimuli for generation of mediators by
tubular cells include hypoxia, ischemia, infectious agents,
exogenous (for example, antibiotics, xenobiotics) and
endogenous products, (for example, altered lipids, high
glucose, DAMPs, uric acid, paraproteins) or genetic factors,
for example in cystic renal diseases.1 The article by Strutz
discusses this process. In proteinuria, tubular cells are
exposed to reabsorb large quantities of substances, which
are not normally filtered, such as proinflammatory and
profibrotic cytokines, complement components, ferritin,
albumin-bound lipids, and immunoglobulins. In vitro all of
the above are capable of inducing chemokine and cytokine
production by tubular epithelial cells or even their apopto-
sis.1 Furthermore, the increased uptake of filtered proteins in
nephrotic syndrome requires a marked increase in the
turnover of membrane and transport proteins. This taxes
the endoplasmic reticulum, resulting in an endoplasmic
reticulum stress response,9 as illustrated in Figure 2 for
diabetic nephropathy. The significance of proteinuria for
progressive tubulointerstitial fibrosis derives from clinical
studies showing that patients with a higher degree of
proteinuria have a more rapid decline in renal function.13
The correlation between the degree of proteinuria and the
progression of renal insufficiency observed in a number of
therapeutic trials has been interpreted as indicating that
proteinuria per se is responsible for the progression. At
present, there is insufficient evidence for such a cause and
effect interpretation. The persistence of marked proteinuria
may simply indicate that the therapy has had no effect on the
primary glomerular lesions, which therefore progress relent-
lessly as reflected by the persistent proteinuria and the decline
in glomerlular filtration rate. A recent review provides an
excellent and balanced analysis on the relationship between
proteinuria and progression.13
The fibrotic process involves a similar set of players as
initial inflammation: leukocytes, mediators of inflammation
including cytokines, chemokines, and so on. However, these
now fulfill different functions; for example, leukocytes induce
fibroblast and fibrocyte activation with deposition of excess
extra-cellular matrix. As capillary blood supply may also be
lost because of tissue injury, the site of repair may become
chronically hypoxic and thus susceptible to progressive
inflammation unless adequate neo-vascularization occurs.
In this process the persistence of macrophages and lympho-
cytes plays a major role through the production of
proinflammatory, profibrotic cytokines. The articles in this
series by Norman and Fine, Ronco and Chatziantoniou,
Hughes, Bottinger and Schiffer, and Strutz provide further
details.
HYOU1 (ORP150)
CON DN
Figure 2 | Proteinuria and diabetes mellitus cause
endoplasmic reticulum (ER) stress and an unfolded protein
response (UPR) in renal epithelial cells, as illustrated for
example by enhanced immunofluorescence for the UPR gene
HYOU 1 in a biopsy with diabetic nephropathy (DN) and
proteinuria as compared with a normal control (CON) from a
transplant donor biopsy (picture courtesy of M.P. Rastaldi).
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DAMP molecules and TLRs as novel sensors of tissue injury
Apart from proteinuria and hypoxia, cellular stress and injury
of any kind may generate mediators of inflammation. The
danger signal hypothesis proposed by Matzinger14 links
the generation of DAMP molecules during tissue injury to
the activation of TLRs and an immune response (see
Figure 3). TLRs, germline-encoded pattern recognition
receptors, are highly conserved in species as diverse as
Drosophila and humans.15 These receptors were identified as
part of the innate immune system recognizing Pathogen
Associated Molecular Patterns shared by large groups of
microorganisms.15 TLRs are expressed by cells of the immune
system such as macrophages, dendritic cells, neutrophils, B
cells, and natural killer cells. Certain TLRs, including the
endotoxin receptor TLR4, are also expressed in nonimmune
cells, including renal tubular epithelial cells, podocytes,
mesangial, and endothelial cells.10,11 The cellular effects of
TLR vary, depending on the receptor and the cell type in
which the receptors are expressed. They include the
production of proinflammatory cytokines, chemokines, and
other soluble mediators, which contribute to local inflamma-
tion and leucocyte accumulation. Activation of TLRs also
alters the chemokine receptor profile and upregulation of the
surface expression of major histocompatibility complex and
costimulatory molecules on antigen presenting cells, which
promote an effective adaptive immune response. On the basis
of the established role of TLRs in the recognition of
exogenous pathogens as part of the innate immune response,
the danger signal hypothesis proposes to extend the model to
local cellular stress and injury (see Figure 3). DAMP
molecules would be generated by cell and matrix damage
and recognized as endogenous TLR ligands.16 This would
also generate mediators of inflammation and thereby alert
the immune system to local tissue injury. DAMP molecules
could be actively secreted or passively released from stressed
or damaged cells, or from matrix that is being remodeled.
Potential endogenous TLR ligands include heat-shock
proteins binding to TLR2 and TLR4, uric acid, the
nonhistone chromatin-binding protein high mobility group
box 1 for TLR2 and TLR4.16 Furthermore, many components
or fragments of the extracellular matrix such as hyaluronans
(TLR2 and TLR4 ), fibronectin (TLR4), and heparan sulfate
(TLR4) as well as biglycan can serve as DAMPs.11,12,16
Figure 4 illustrates our present understanding about the
distribution of TLRs in the kidney. Evidence for the
involvement of DAMPs as endogenous TLR ligands has been
provided in the pathogenesis of ischemia–reperfusion in-
jury.10,17 The role of TLR2 and TLR4 in ischemia–reperfusion
injury was demonstrated as TLR2- and TLR4-deficient mice
were protected against kidney ischemia–reperfusion in-
jury.10,17 TLR2 on BM-derived cells and TLR4 on both
BM-derived cells and renal parenchymal cells appear to
contribute to inflammation and injury within the kidney in
the ischemia–reperfusion injury model. Similarly, in experi-
mental immune-mediated glomerulonephritis, TLR2 on both
BM-derived and parenchymal kidney cells seems to play a
role in amplifying the inflammatory response. Recently,
HSP60 was identified as a DAMP molecule for TLR
contributing to nephrotoxic serum nephritis.18 At present,
evidence for activation of intrarenal TLRs by ligands
generated in response to renal injury is restricted to acute
models. However, many of the endogenous ligands impli-
cated (for example,, biglycan, hyaluronans, heat-shock
proteins) are known to be increased in kidneys with
progressive fibrosis, and could thus activate TLRs with
release of mediators of inflammation and fibrosis, thereby
perpetuating progression. Very recently, a study linked a
novel and direct effect of TLR4 activation on fibrosis to TLR
to transforming growth factor b signaling through the
adaptor protein BAMBI and activin receptor membrane-
bound inhibitor, thereby enhancing progression in models of
hepatic cirrhosis.19 Thus, the contribution of DAMPs and
TLRs to progressive renal insufficiency may prove to become
a fertile field of research in the next few years.
CONTRIBUTION OF CHEMOKINES AND CHEMOKINE
RECEPTORS TO PROGRESSIVE RENAL FIBROSIS
Tubulointerstitial leukocyte recruitment and activation
depend on chemokine-mediated processes.20,21 Both tubular
cells as well as interstitial fibroblasts will produce chemokines
during hypoxia and hyperglycemia upon stimulation with
proinflammatory cytokines and after TLR activation by
endogenous DAMPs. Furthermore, activated renal fibroblasts
could secrete chemokines such as CCL2/MCP-1 and
Activation of renal
parenchymal cells 
and resident Mφ/DCs
Chemokines, proinflammatory
and profibrotic mediators
Inflammatory cell infiltrate and
myofibroblast proliferation
Proteases and
hydrolases Complement
Necrotic cell
Generation of
extracellular DAMPs
C3a, C5a
Release of
intracellular
DAMPs
DAMP
receptor
Figure 3 | Schematic illustration of the generation of Danger
Associated Molecular Pattern (DAMP) molecules and their
effects on receptors such as TLRs on intrinsic renal and
inflammatory cells, eventually contributing to cell activation,
infiltration, and fibrosis.
864 Kidney International (2008) 74, 860–866
p r o g r e s s i o n o f r e n a l d i s e a s e DO Schlondorff: Pathophysiology of progressive renal disease
CXCL1/MIP-2, which, in turn, may attract further macro-
phages. Renal fibroblasts produce interstitial matrix components
including collagen upon stimulation by activated macro-
phages, indicating that chemokines, either directly or
indirectly through macrophage recruitment, contribute to
interstitial collagen deposition and fibrosis. The chemokine
CCL2/MCP-1 is expressed by tubular epithelial cells in
animal models of progressive nephropathies and renal
fibrosis and, when examined, correlated with M/M infiltra-
tion.20,21 Similar results have been reported for various
chemokines in biopsies from patients with progressive renal
diseases, including diabetes-induced nephropathy.19,20 The
functional role of chemokines in interstitial disease was
confirmed by several animal studies using chemokine
antagonists or chemokine-deficient mice. The models
included the interstitial involvement of immune complex-
mediated glomerulonephritis, Alport’s disease, nephrotic
syndrome, diabetic renal involvement, and obstructive
nephropathy.19,20
Chemokines may also contribute to the recruitment of
BM-derived fibrocytes to the renal interstitium in progressive
renal disease. Although in the kidney the activated myofi-
broblast is considered to be the cell responsible for most of
the excess collagen deposition, the fibrocyte has been
implicated in progressive fibrosis in pulmonary, liver, and
kidney disease.22 Fibrocytes had been identified earlier as a
unique BM-derived cell population with a high capacity for
collagen 1 synthesis. They circulate in low number in the
peripheral blood, and the chemokine/chemokine receptor
(CCR/CXCR) system directs their recruitment to sites of
tissue injury and fibrosis. Fibrocytes, isolated from human
and mice, express chemokine receptors such as CCR2, CCR3,
CCR5, CCR7, and CXCR4, which direct their migration.20–22
In kidneys of mice with experimental unilateral ureteral
obstruction, fibrocytes were detected 7 days after uretereral
ligation.22 At present, there are insufficient data to assign a
specific ckemokine and receptor pair to the recruitment of
fibrocytes into the injured kidney. Finally, the distinction
between fibrocytes and other cells of BM origin remains fluid
at present. BM-derived fibrocytes express surface markers
(CXCR4, cluster designation (CD)-44, and probably CD34),
overlapping with BM-derived ‘precursor cells’ (for endothe-
lieal or vascular smooth muscle cells). In summary, these
findings point toward a role for chemokines and their
receptors in leukocyte-mediated progressive tubulointerstitial
damage and fibrosis ultimately leading to end-stage renal
disease. Conversely, inhibiting tubulointerstitial leukocyte
recruitment by blockade of chemokine action may mitigate
chronic renal inflammation and subsequent fibrosis.20 On the
basis of effectiveness of CCR5 antagonists in HIV treatment,
hopefully chemokine antagonists with sufficiently long half-
lives and effectiveness will become available for testing in
human progressive renal disease, including transplant
nephropathy.
OUTCOME OF TISSUE INJURY, INFLAMMATION AND REPAIR
As long as the inflammatory response is short-lived and the
injury locally limited with minimal disruption of the
underlying tissue architecture, the repair process will restore
almost all normal histology and function. Obviously, this
requires that no new insults occur, that production of
proinflammatory mediators ceases, or that their action
• Mesangial cell
• TLR 2,3,4
• Podocyte and
  endothelial cell
• TLR2,4
• Vascular smooth muscle cell
• TLR3
• Proximal tubular
epithelial cell
• TLR2
• TLR4
Resident and
infiltrating: 
• MP/DC
• TLR2,4
• TLR7
• TLR9
• Collecting tubular
epithelial cell
• TLR2,3,4
Figure 4 | Distribution of TLRs on renal cells as well as resident and infiltrating monocyte/macrophages and dendritic cells.
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becomes neutralized, and that leukocytes at the site of tissue
injury disappear by either undergoing apoptosis or leaving
the site through blood or lymphatic vessels (reverse
migration). Furthermore, the extracellular matrix scaffold
must be remodeled to its original form and the parenchymal
cells must replace the lost cells in the original pattern. Under
these rare conditions, an early fibrotic process may be
reversible, as recently reported.23 Unfortunately, this scenario
is the exception rather than the rule. Under most conditions,
disruption of the intricate tissue structure takes place,
so that repair can only occur in an incomplete manner,
that is with fibrosis. Depending on the degree of tissue
distortion resulting from the fibrosis and continued cell
stress, the process of repair may come to a relative standstill,
or damage will continue to progress relentlessly to renal
failure.
THERAPEUTIC OUTLOOK
The advent of therapies that block the angiotensin system has
led to major advances in slowing the progression of most
forms of chronic renal diseases. Unfortunately, the therapeu-
tic benefits of interfering with the renin–angiotensin system
may approach their limits. Additional pathways of preventing
progression of renal diseases need to be studied. These
pathways could include preservation or growth of endothelial
cells and angiogenesis, preventing ischemia-hypoxia and their
detrimental responses, reducing or antagonizing reactive
oxygen species, interfering with TLRs and their endogenous
DAMP ligands, blocking or resolving proinflammatory and
profibrotic inflammatory infiltrates, altering the profibrotic
cytokine profile, enhancing removal of excessive matrix, and
reestablishing a favorable balance between apoptosis and cell
proliferation.
Finally, novel treatments aimed at the causes of the
different glomerular diseases, including that which targets
secondary tubolointerstitial involvement, need to be deve-
loped.
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